{
    "@context": {
        "ct": "https://clinicaltrials.gov/",
        "drug": "https://drugcentral.org/drugcard/",
        "file": "https://clinicaltrials.gov/ct2/show/",
        "mesh": "https://www.ncbi.nlm.nih.gov/mesh/?term=",
        "schema": "https://schema.org/"
    },
    "@graph": [
        {
            "@id": "drug:26",
            "@type": "schema:Drug",
            "schema:name": "fluorouracil",
            "schema:study": [
                {
                    "@id": "file:NCT00010088"
                },
                {
                    "@id": "file:NCT00010075"
                }
            ],
            "schema:url": [
                "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL185",
                {
                    "@id": "https://www.ncbi.nlm.nih.gov/mesh/?term=D005472"
                }
            ]
        },
        {
            "@id": "file:NCT00010023",
            "@type": "schema:MedicalStudy",
            "schema:MedicalCondition": "Cancer",
            "schema:alternateName": "A Phase I Study of Oral Fluoropyrimidine Capecitabine (Xeloda Roche) Combined With Intravenous Cisplatin in Patients With Advanced Cancer of the Digestive System",
            "schema:phase": "Phase 1",
            "schema:title": "Capecitabine Combined With Cisplatin in Treating Patients With Locally Advanced or Metastatic Solid Tumors"
        },
        {
            "@id": "drug:480",
            "@type": "schema:Drug",
            "schema:name": "capecitabine",
            "schema:study": {
                "@id": "file:NCT00010023"
            },
            "schema:url": [
                "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1773",
                {
                    "@id": "https://www.ncbi.nlm.nih.gov/mesh/?term=D000069287"
                }
            ]
        },
        {
            "@id": "https://www.ncbi.nlm.nih.gov/mesh/?term=Cholangiocarcinoma%5BMeSH%20Terms%5D",
            "schema:citedby": {
                "@id": "file:NCT00010088"
            }
        },
        {
            "@id": "https://www.ncbi.nlm.nih.gov/mesh/?term=Breast%20Neoplasms%5BMeSH%20Terms%5D",
            "schema:citedby": [
                {
                    "@id": "file:NCT00010075"
                },
                {
                    "@id": "file:NCT00010010"
                }
            ]
        },
        {
            "@id": "file:NCT00010010",
            "@type": "schema:MedicalStudy",
            "schema:MedicalCondition": "Breast Cancer",
            "schema:about": [
                {
                    "@id": "https://www.ncbi.nlm.nih.gov/mesh/?term=Breast%20Neoplasms%5BMeSH%20Terms%5D"
                },
                {
                    "@id": "drug:1122"
                }
            ],
            "schema:alternateName": "A Phase II Study of the Combination of Exemestane and Goserelin in Premenopausal Women With Metastatic Hormone Receptor Positive Breast Cancer",
            "schema:phase": "Phase 2",
            "schema:title": "Exemestane Plus Goserelin in Treating Premenopausal Women With Metastatic Breast Cancer"
        },
        {
            "@id": "file:NCT00010075",
            "@type": "schema:MedicalStudy",
            "schema:MedicalCondition": "Breast Cancer",
            "schema:about": [
                {
                    "@id": "https://www.ncbi.nlm.nih.gov/mesh/?term=Breast%20Neoplasms%5BMeSH%20Terms%5D"
                },
                {
                    "@id": "drug:26"
                }
            ],
            "schema:alternateName": "Study Of The Survival Without Degradation To The Quality Of Life During Chemotherapy For Metastatic Breast Cancer In Women",
            "schema:phase": "Phase 2",
            "schema:title": "Combination Chemotherapy in Treating Older Women With Metastatic Breast Cancer"
        },
        {
            "@id": "drug:1122",
            "@type": "schema:Drug",
            "schema:name": "exemestane",
            "schema:study": {
                "@id": "file:NCT00010010"
            },
            "schema:url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200374"
        },
        {
            "@id": "https://www.ncbi.nlm.nih.gov/mesh/?term=Pancreatic%20Neoplasms%5BMeSH%20Terms%5D",
            "schema:citedby": {
                "@id": "file:NCT00010088"
            }
        },
        {
            "@id": "https://www.ncbi.nlm.nih.gov/mesh/?term=Bile%20Duct%20Neoplasms%5BMeSH%20Terms%5D",
            "schema:citedby": {
                "@id": "file:NCT00010088"
            }
        },
        {
            "@id": "file:NCT00010088",
            "@type": "schema:MedicalStudy",
            "schema:MedicalCondition": "Extrahepatic Bile Duct Cancer",
            "schema:about": [
                {
                    "@id": "https://www.ncbi.nlm.nih.gov/mesh/?term=Pancreatic%20Neoplasms%5BMeSH%20Terms%5D"
                },
                {
                    "@id": "drug:26"
                },
                {
                    "@id": "https://www.ncbi.nlm.nih.gov/mesh/?term=Bile%20Duct%20Neoplasms%5BMeSH%20Terms%5D"
                },
                {
                    "@id": "https://www.ncbi.nlm.nih.gov/mesh/?term=Cholangiocarcinoma%5BMeSH%20Terms%5D"
                }
            ],
            "schema:alternateName": "Study Of Gemcitabine, Leukovorin, And Fluorouracil Used To Treat Locally Advanced And Metastatic Pancreatic And Biliary Adenocarcinomas",
            "schema:phase": "Phase 2",
            "schema:title": "Chemotherapy in Treating Patients With Locally Advanced or Metastatic Cancer of the Pancreas or Bile Duct"
        },
        {
            "@id": "drug:4392",
            "@type": "schema:Drug",
            "schema:name": "cisplatin",
            "schema:study": {
                "@id": "file:NCT00010023"
            },
            "schema:url": {
                "@id": "https://www.ncbi.nlm.nih.gov/mesh/?term=D002945"
            }
        }
    ]
}